024 Pharma, Inc.
company.status.inactiveCIK 1307969fmd_0G5MTMWKGK4F5ER2AS1PWE75HSManufacturing · Plastics Products, NECTemplate: Standard
Coverage: Jan 01, 2010 to Mar 31, 2017, 14 periods
| Line item | FY2010 | FY2011 | FY2016 |
|---|---|---|---|
| Total revenues | 0 | 0 | 1 |
| Cost of revenue | 0 | 0 | 0 |
| Gross profit | 0 | 0 | 1 |
| Selling, general and administrative | 1 | 1 | – |
| Total operating expenses | 1 | 1 | – |
| Compensation and benefits | – | – | 0 |
| Operating income | (1) | (0) | – |
| Interest expense | 0 | 0 | 0 |
| Interest and investment income | 0 | 0 | – |
| Other non-operating income (expense) | 2 | 0 | – |
| Income before taxes | 1 | (0) | 1 |
| Income tax expense | 0 | 0 | 0 |
| Net income from continuing operations | 1 | (0) | 1 |
| Net income | 1 | (0) | 1 |